1. Home
  2. CPIX vs NXPL Comparison

CPIX vs NXPL Comparison

Compare CPIX & NXPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPIX
  • NXPL
  • Stock Information
  • Founded
  • CPIX 1999
  • NXPL 1997
  • Country
  • CPIX United States
  • NXPL United States
  • Employees
  • CPIX N/A
  • NXPL N/A
  • Industry
  • CPIX Biotechnology: Pharmaceutical Preparations
  • NXPL Telecommunications Equipment
  • Sector
  • CPIX Health Care
  • NXPL Telecommunications
  • Exchange
  • CPIX Nasdaq
  • NXPL Nasdaq
  • Market Cap
  • CPIX 68.7M
  • NXPL 32.5M
  • IPO Year
  • CPIX 2009
  • NXPL N/A
  • Fundamental
  • Price
  • CPIX $5.15
  • NXPL $1.06
  • Analyst Decision
  • CPIX
  • NXPL
  • Analyst Count
  • CPIX 0
  • NXPL 0
  • Target Price
  • CPIX N/A
  • NXPL N/A
  • AVG Volume (30 Days)
  • CPIX 4.2M
  • NXPL 110.4K
  • Earning Date
  • CPIX 03-04-2025
  • NXPL 04-10-2025
  • Dividend Yield
  • CPIX N/A
  • NXPL N/A
  • EPS Growth
  • CPIX N/A
  • NXPL N/A
  • EPS
  • CPIX N/A
  • NXPL N/A
  • Revenue
  • CPIX $36,785,442.00
  • NXPL $66,482,000.00
  • Revenue This Year
  • CPIX N/A
  • NXPL N/A
  • Revenue Next Year
  • CPIX N/A
  • NXPL N/A
  • P/E Ratio
  • CPIX N/A
  • NXPL N/A
  • Revenue Growth
  • CPIX N/A
  • NXPL 179.89
  • 52 Week Low
  • CPIX $1.04
  • NXPL $0.71
  • 52 Week High
  • CPIX $6.43
  • NXPL $2.68
  • Technical
  • Relative Strength Index (RSI)
  • CPIX 68.22
  • NXPL 48.69
  • Support Level
  • CPIX $4.12
  • NXPL $0.89
  • Resistance Level
  • CPIX $5.29
  • NXPL $1.08
  • Average True Range (ATR)
  • CPIX 0.74
  • NXPL 0.08
  • MACD
  • CPIX 0.17
  • NXPL -0.00
  • Stochastic Oscillator
  • CPIX 70.57
  • NXPL 71.74

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About NXPL NextPlat Corp

NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.

Share on Social Networks: